Bayer Aktiengesellschaft (BAYN.DE)
EUR 19.22
(-0.56%)
EUR 19.22
(-0.56%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 4.2 Billion EUR | -3.33% |
| 2022 | 10.44 Billion EUR | 27.28% |
| 2021 | 6.96 Billion EUR | -2.8% |
| 2020 | -11.48 Billion EUR | -0.83% |
| 2019 | 8.76 Billion EUR | 52.54% |
| 2018 | 6.25 Billion EUR | -17.91% |
| 2017 | 7.75 Billion EUR | -23.73% |
| 2016 | 7.82 Billion EUR | 7.46% |
| 2015 | 9.6 Billion EUR | 17.35% |
| 2014 | 8.64 Billion EUR | 7.78% |
| 2013 | 8 Billion EUR | -4.79% |
| 2012 | 8.42 Billion EUR | 21.71% |
| 2011 | 7.19 Billion EUR | 10.05% |
| 2010 | 6.28 Billion EUR | 8.1% |
| 2009 | 5.81 Billion EUR | -7.2% |
| 2008 | 6.26 Billion EUR | 24.23% |
| 2007 | 5.86 Billion EUR | 7.89% |
| 2006 | 4.67 Billion EUR | 0.67% |
| 2005 | 4.64 Billion EUR | 12.55% |
| 2004 | 3.38 Billion EUR | 17.0% |
| 2003 | 3.52 Billion EUR | -27.91% |
| 2002 | 4.89 Billion EUR | 29.96% |
| 2001 | 4.13 Billion EUR | -28.8% |
| 2000 | 5.28 Billion EUR | -14.53% |
| 1999 | 6.59 Billion EUR | -32.32% |
| 1998 | 9.13 Billion EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 4.36 Billion EUR | 30.8% |
| 2024 Q2 | 2.07 Billion EUR | -59.64% |
| 2023 Q3 | 1.43 Billion EUR | -38.78% |
| 2023 FY | - EUR | -3.33% |
| 2023 Q1 | 4.42 Billion EUR | 64.4% |
| 2023 Q4 | 3.83 Billion EUR | 166.62% |
| 2023 Q2 | 2.34 Billion EUR | -46.96% |
| 2022 Q1 | 5.33 Billion EUR | 230.38% |
| 2022 FY | - EUR | 27.28% |
| 2022 Q2 | 2.66 Billion EUR | -50.14% |
| 2022 Q3 | 2.33 Billion EUR | -12.28% |
| 2022 Q4 | 2.69 Billion EUR | 15.37% |
| 2021 Q1 | 4.24 Billion EUR | 98.92% |
| 2021 Q2 | -515 Million EUR | -112.14% |
| 2021 Q4 | 1.61 Billion EUR | 15.76% |
| 2021 Q3 | 1.39 Billion EUR | 371.07% |
| 2021 FY | - EUR | -2.8% |
| 2020 Q4 | 2.13 Billion EUR | 71.24% |
| 2020 Q3 | 1.24 Billion EUR | 112.97% |
| 2020 Q2 | -9.6 Billion EUR | -352.42% |
| 2020 Q1 | 3.8 Billion EUR | 85.29% |
| 2020 FY | - EUR | -0.83% |
| 2019 Q2 | 2.53 Billion EUR | -22.89% |
| 2019 Q1 | 3.28 Billion EUR | 606.78% |
| 2019 Q3 | 2.57 Billion EUR | 1.58% |
| 2019 Q4 | 2.05 Billion EUR | -20.3% |
| 2019 FY | - EUR | 52.54% |
| 2018 FY | - EUR | -17.91% |
| 2018 Q1 | 3.25 Billion EUR | 302.84% |
| 2018 Q2 | 2.2 Billion EUR | -32.37% |
| 2018 Q4 | -649 Million EUR | -111.86% |
| 2018 Q3 | 5.47 Billion EUR | 148.23% |
| 2017 Q2 | 3.07 Billion EUR | -20.55% |
| 2017 Q4 | 809 Million EUR | -60.44% |
| 2017 FY | - EUR | -23.73% |
| 2017 Q1 | 3.86 Billion EUR | 135.71% |
| 2017 Q3 | 2.04 Billion EUR | -33.45% |
| 2016 Q3 | 2.58 Billion EUR | -13.39% |
| 2016 FY | - EUR | 7.46% |
| 2016 Q4 | 1.64 Billion EUR | -36.59% |
| 2016 Q2 | 2.98 Billion EUR | -12.32% |
| 2016 Q1 | 3.4 Billion EUR | 92.11% |
| 2015 Q1 | 2.82 Billion EUR | 139.97% |
| 2015 FY | - EUR | 17.35% |
| 2015 Q4 | 1.77 Billion EUR | -24.61% |
| 2015 Q3 | 2.35 Billion EUR | -13.71% |
| 2015 Q2 | 2.72 Billion EUR | -3.37% |
| 2014 Q3 | 2.12 Billion EUR | -6.56% |
| 2014 Q4 | 1.17 Billion EUR | -44.58% |
| 2014 FY | - EUR | 7.78% |
| 2014 Q1 | 2.83 Billion EUR | 102.0% |
| 2014 Q2 | 2.27 Billion EUR | -19.81% |
| 2013 FY | - EUR | -4.79% |
| 2013 Q1 | 2.47 Billion EUR | 55.42% |
| 2013 Q4 | 1.4 Billion EUR | -27.73% |
| 2013 Q2 | 2.18 Billion EUR | -12.02% |
| 2013 Q3 | 1.94 Billion EUR | -11.05% |
| 2012 Q1 | 2.47 Billion EUR | 133.36% |
| 2012 Q2 | 1.68 Billion EUR | -31.79% |
| 2012 FY | - EUR | 21.71% |
| 2012 Q4 | 1.59 Billion EUR | 0.38% |
| 2012 Q3 | 1.58 Billion EUR | -5.92% |
| 2011 Q3 | 1.87 Billion EUR | -10.04% |
| 2011 Q1 | 1.9 Billion EUR | 75.48% |
| 2011 Q4 | 1.06 Billion EUR | -43.32% |
| 2011 Q2 | 2.08 Billion EUR | 9.3% |
| 2011 FY | - EUR | 10.05% |
| 2010 Q1 | 1.97 Billion EUR | 280.73% |
| 2010 FY | - EUR | 8.1% |
| 2010 Q3 | 1.28 Billion EUR | -33.93% |
| 2010 Q2 | 1.94 Billion EUR | -1.72% |
| 2010 Q4 | 1.08 Billion EUR | -15.43% |
| 2009 Q4 | 519 Million EUR | -64.79% |
| 2009 FY | - EUR | -7.2% |
| 2009 Q3 | 1.47 Billion EUR | -22.05% |
| 2009 Q2 | 1.89 Billion EUR | -2.07% |
| 2009 Q1 | 1.93 Billion EUR | 75.07% |
| 2008 Q4 | 1.1 Billion EUR | -17.32% |
| 2008 Q2 | 1.77 Billion EUR | -13.67% |
| 2008 Q1 | 2.05 Billion EUR | 693.44% |
| 2008 FY | - EUR | 24.23% |
| 2008 Q3 | 1.33 Billion EUR | -24.8% |
| 2007 Q2 | 1.57 Billion EUR | -11.33% |
| 2007 Q1 | 1.77 Billion EUR | 306.99% |
| 2007 Q3 | 1.43 Billion EUR | -8.46% |
| 2007 FY | - EUR | 7.89% |
| 2007 Q4 | 259 Million EUR | -82.01% |
| 2006 Q1 | 1.55 Billion EUR | 134.48% |
| 2006 Q2 | 1.1 Billion EUR | -28.81% |
| 2006 Q3 | 1.22 Billion EUR | 11.13% |
| 2006 Q4 | 435.72 Million EUR | -64.49% |
| 2006 FY | - EUR | 0.67% |
| 2005 Q3 | 1.25 Billion EUR | 18.69% |
| 2005 Q2 | 1.05 Billion EUR | -26.46% |
| 2005 Q1 | 1.43 Billion EUR | 78.71% |
| 2005 FY | - EUR | 12.55% |
| 2005 Q4 | 661.47 Million EUR | -47.25% |
| 2004 Q4 | 803.77 Million EUR | 229.87% |
| 2004 Q2 | 523.05 Million EUR | -36.2% |
| 2004 Q3 | 243.66 Million EUR | -53.41% |
| 2004 FY | - EUR | 17.0% |
| 2004 Q1 | 819.77 Million EUR | 129.82% |
| 2003 Q4 | -2.74 Billion EUR | -13452.14% |
| 2003 FY | - EUR | -27.91% |
| 2003 Q3 | 20.58 Million EUR | -95.45% |
| 2003 Q2 | 452.8 Million EUR | -57.71% |
| 2003 Q1 | 1.07 Billion EUR | 204.65% |
| 2002 FY | - EUR | 29.96% |
| 2002 Q3 | 1.05 Billion EUR | 326.95% |
| 2002 Q4 | -1.02 Billion EUR | -196.78% |
| 2002 Q1 | 820.31 Million EUR | 700.05% |
| 2002 Q2 | 247.62 Million EUR | -69.81% |
| 2001 Q1 | 848.17 Million EUR | 0.0% |
| 2001 Q3 | -332.6 Million EUR | -165.59% |
| 2001 Q2 | 507.11 Million EUR | -40.21% |
| 2001 FY | - EUR | -28.8% |
| 2001 Q4 | 102.53 Million EUR | 130.83% |
| 2000 FY | - EUR | -14.53% |
| 1999 FY | - EUR | -32.32% |
| 1998 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Sanofi | 11.99 Billion EUR | 64.916% |